|Page (1) of 1 - 05/18/17||email article||print page|
(May 18, 2017)
DGAP-News: CO.DON AG / Key word(s): Regulatory Admission
CO.DON: decisive step towards European expansion
- Positive opinion from relevant committee for EU approval of articular cartilage product
Berlin / Teltow, 18 May 2017 - In the course of the ongoing application for EU marketing authorisation, CO.DON AG received today the official positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for its articular cartilage product. The recommended indication is the repair of symptomatic articular cartilage defects on the femoral condyle and the knee patella; defects of up to 10 cm² for adults. The CHMP assessment forms the basis for a decision by the European Commission on EU-wide marketing authorisation for the product. In the past the European Commission has followed the recommendations of CHMP for the great majority of applications.
Dr Bernd Wegener, Chairman of the Supervisory Board of CO.DON AG. "Obtaining EU marketing authorisation for the articular cartilage product is CO.DON AG's most important strategic goal and it is now within reach. This great success is the result of the work carried out by all the employees of CO.DON AG and I would like to take this opportunity to thank them most sincerely."
Dirk Hessel, CEO of co.don AG: "This positive opinion represents another decisive step towards EU-wide approval. The CHMP recommendation covers all the indications in the application. Our preparations for market entry mean we can start with the practical implementation as soon as marketing authorisation is granted. If the European Commission follows the recommendation, we are ready to treat the first patients outside Germany. We soon hope to be able to meet the high demand for our advanced methods across the EU, especially since no comparable product is currently available in our target markets."
Investor Relations and Press Contact:
|Listed:||Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange|
|End of News||DGAP News Service|
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder , Review Seeker , DMN Newswire Newsletter